GlassScriptPhysician profile
Ashley C Hodges
NPI 1538628839
$909.78
in general payments reported to CMS, 2019-2025
15 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $191 · 2024: $391 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.74 |
| Education | $125.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $219.78 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $152.73 | 2023-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $104.26 | 2023-2024 | |
| Novo Nordisk INC | $81.39 | 2023-2025 | Wegovy |
| Millicent US INC | $69.91 | 2023-2024 | Femring, Intrarosa |
| Amgen INC. | $55.10 | 2025 | Evenity |
| Organon LLC | $43.33 | 2025 | Nexplanon |
| Pfizer INC. | $35.52 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $34.65 | 2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $22.57 | 2024 | |
| Lilly USA, LLC | $20.34 | 2025 | Zepbound |
| Evofem Biosciences, INC. | $20.00 | 2024 | |
| Davol INC. | $18.31 | 2023 | |
| Abbvie INC. | $16.46 | 2025 | |
| Exeltis, USA INC. | $15.43 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.